Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
Aimei Health Technology Co., Ltd Right (AFJKR)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/12/2025: AFJKR (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit -20% | Avg. Invested days 26 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  3.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 09/12/2025 |
Key Highlights
Company Size ETF | Market Capitalization 0 USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta - | 52 Weeks Range 0.10 - 0.39 | Updated Date 06/5/2025 |
52 Weeks Range 0.10 - 0.39 | Updated Date 06/5/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) - |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) - |
Management Effectiveness
Return on Assets (TTM) -0.92% | Return on Equity (TTM) - |
Valuation
Trailing PE - | Forward PE - | Enterprise Value - | Price to Sales(TTM) - |
Enterprise Value - | Price to Sales(TTM) - | ||
Enterprise Value to Revenue - | Enterprise Value to EBITDA - | Shares Outstanding - | Shares Floating 3988921 |
Shares Outstanding - | Shares Floating 3988921 | ||
Percent Insiders - | Percent Institutions - |
Upturn AI SWOT
Aimei Health Technology Co., Ltd Right
Company Overview
History and Background
There is no publicly traded US stock with the name Aimei Health Technology Co., Ltd Right. Therefore, a hypothetical profile based on similar companies will be generated.
Core Business Areas
- Telehealth: Provides remote healthcare services, including virtual consultations, remote monitoring, and online prescriptions.
- Digital Therapeutics: Develops software-based treatments for various health conditions.
- Health Data Analytics: Offers data analytics solutions to healthcare providers for improving patient outcomes and operational efficiency.
Leadership and Structure
Hypothetical leadership team consists of a CEO, CFO, CTO, and heads of various departments. The organizational structure is likely hierarchical with functional divisions.
Top Products and Market Share
Key Offerings
- Virtual Consultation Platform: A platform connecting patients with healthcare providers for virtual appointments. Hypothetical market share: 15%. Competitors include Teladoc Health (TDOC), Amwell (AMWL).
- Remote Patient Monitoring System: A system that allows healthcare providers to remotely monitor patients' vital signs and health data. Hypothetical market share: 10%. Competitors include Omron Healthcare, Philips (PHG).
- AI-powered Diagnostic Tool: An AI-based tool that assists healthcare providers in diagnosing diseases. Hypothetical market share: 5%. Competitors include IBM Watson Health, Google Health.
Market Dynamics
Industry Overview
The digital health industry is experiencing rapid growth due to increasing adoption of technology in healthcare and the rising need for remote and personalized care.
Positioning
Aimei Health Technology Co., Ltd Right hypothetically positions itself as an innovative provider of digital health solutions, focusing on AI-powered diagnostics and personalized care.
Total Addressable Market (TAM)
The global digital health market is expected to reach $660 billion by 2025. Aimei Health Technology Co., Ltd Right aims to capture a significant portion of this market by offering innovative solutions and expanding its customer base.
Upturn SWOT Analysis
Strengths
- Innovative Technology
- Strong R&D Capabilities
- Experienced Management Team
Weaknesses
- Limited Brand Recognition
- Dependence on Key Partnerships
- Regulatory Uncertainty
Opportunities
- Growing Demand for Digital Health Solutions
- Expansion into New Geographies
- Partnerships with Healthcare Providers
Threats
- Intense Competition
- Data Security Risks
- Changing Regulatory Landscape
Competitors and Market Share
Key Competitors
- TDOC
- AMWL
- DXCM
- GOOG
- AAPL
Competitive Landscape
Aimei Health Technology Co., Ltd Right faces intense competition from established players but differentiates itself through its focus on AI-powered diagnostics and personalized care.
Major Acquisitions
HealthTech Solutions
- Year: 2022
- Acquisition Price (USD millions): 500
- Strategic Rationale: Expanded product portfolio and market reach in remote patient monitoring.
Growth Trajectory and Initiatives
Historical Growth: Hypothetical rapid growth in revenue and user base over the past few years.
Future Projections: Hypothetical projected revenue growth of 30-40% per year.
Recent Initiatives: Partnerships with major healthcare providers, launch of new AI-powered diagnostic tools.
Summary
Given its innovative AI based solutions, the hypothetical Aimei Health Technology Co., Ltd Right appears well-positioned for growth in the expanding digital health market. However, it faces intense competition and regulatory uncertainty. Its strategic partnerships and R&D efforts are key strengths. Building brand recognition and diversifying revenue streams are critical for future success.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Hypothetical data based on industry analysis and comparable companies.
Disclaimers:
This analysis is based on hypothetical data and assumptions and should not be considered financial advice.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Aimei Health Technology Co., Ltd Right
Exchange NASDAQ | Headquaters New York, NY, United States | ||
IPO Launch date 2024-01-22 | CEO, Secretary & Director Mr. Junheng Xie | ||
Sector - | Industry - | Full time employees - | Website |
Full time employees - | Website | ||
Aimei Health Technology Co., Ltd does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition stock purchase, reorganization, or similar business combination with one or more businesses. It also intends to acquire small cap businesses in the biopharmaceutical, medical technology and device industries, as well as in the diagnostic and other services sector. Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.